Effects of Aerobic Exercise Within a Behavioral Treatment Program for Chronic Headaches
14 января 2013 г. обновлено: Donald Penzien, University of Mississippi Medical Center
Additive Effects of Aerobic Exercise to a Standard Behavioral Self-Management Program for Chronic Headaches
This proposed study seeks to examine whether adding an aerobic exercise prescription to a behavioral treatment program for chronic headaches will improve headache frequency and intensity, headache-related disability, and mood.
It is hypothesized that participants who receive the exercise prescription at the start of treatment will show greater gains than those who receive the prescription halfway through treatment.
It is also predicted that participants who begin the exercise component halfway through treatment will demonstrate greater improvement in the second half of treatment compared to the first half.
Обзор исследования
Статус
Завершенный
Условия
Вмешательство/лечение
Подробное описание
Aerobic exercise has long been discussed as a potential treatment for chronic headaches, though research in this area has been somewhat limited. It is warranted to consider the effectiveness of aerobic exercise as part of a larger headache management intervention. Early research in this area suggests that including an exercise component in conjunction with other effective forms of headache management, such as progressive muscle relaxation, biofeedback, and stress management, is associated with improvement in number of days with a headache, headache pain intensity and mood. None of these studies have specifically analyzed the effectiveness of the aerobic exercise component, though Lemestra et al. (2002) noted that participants who continued with their exercise regimen had better overall outcomes three months after the intervention ended.
Given the high rates of obesity and the fact that many people do not meet the minimum daily requirement for exercise, it is worthwhile to investigate the additive effect of exercise to behavioral headache interventions.
Тип исследования
Интервенционный
Регистрация (Действительный)
5
Фаза
- Непригодный
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
Mississippi
-
Jackson, Mississippi, Соединенные Штаты, 39216
- University of Mississippi Medical Center
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
От 18 лет до 64 года (Взрослый)
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Женский
Описание
Inclusion Criteria:
- Diagnosis of chronic headache (according to International Headache Association (IHA) guidelines) by research personnel
- Interested in receiving behavioral treatment for chronic headaches
- Engaged in less than 60 minutes/week of physical activity in the past 3 months
- Physically capable of engaging in a regular exercise routine
- Interested in in taking part in a regular exercise routine
- Regular internet access (at least once a week)
Exclusion Criteria:
- Males
- Unable to access internet at least once a week
- Currently engaging in regular exercise
- Not interested in participating in regular exercise
- Not capable of safely exercising
- Pregnant, nursing, or planning on becoming pregnant during the course of the study
- Does not meet IHA diagnostic criteria for chronic headache
- Not interested in behavioral headache treatment
- Diagnosis of Medication Overuse Headache, or headaches related to a physical or neurological disorder
- Cognitive or other forms of impairment that would decrease ability to fully engage in treatment
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Exercise-Start (ES)
The ES group will receive standard behavioral treatment in the Self-Management Training Program for Chronic Headaches.
In addition to this material, participants in this group will receive an exercise prescription for 20 minutes of moderate-intensity aerobic activity at the beginning of Week 1.
The exercise prescription will increase to 25 minutes in Week 2, and 30 minutes in Week 3.
They are asked to maintain 30 minutes per day of exercise through Week 8. Participants choose the type of exercise, and have the option to break it up into 10-minute increments throughout the day.
|
This behavioral treatment program consists of behavioral approaches to headache management: progressive muscle relaxation, stress-management training, and biofeedback.
Skills for these techniques are presented during the clinic sessions, and supplemented with workbooks and audio CDs.
In addition, all participants will receive a graduated exercise prescription of 20-30 minutes of moderate-intensity exercise, five days per week.
They will be instructed to assess the intensity of their exercise using the Borg perceived exertion scale.
Client contact sessions are as follows: Clinic Session (CS)1; Phone Session (PS) 1 (end of week1), CS 2 (end of week 4); PS 2 (end of week 6); CS 3 (end of week 8).
|
|
Экспериментальный: Exercise-Middle (EM)
The EM group will receive standard behavioral treatment in the Self-Management Training Program for Chronic Headaches.In addition to this material, participants in this group will receive an exercise prescription for 20 minutes of moderate-intensity aerobic activity at the beginning of Week 5.
The exercise prescription will increase to 25 minutes in Week 6, and 30 minutes in Week 7.
They are asked to maintain 30 minutes per day of exercise through Week 8. Participants choose the type of exercise, and have the option to break it up into 10-minute increments throughout the day.
|
This behavioral treatment program consists of behavioral approaches to headache management: progressive muscle relaxation, stress-management training, and biofeedback.
Skills for these techniques are presented during the clinic sessions, and supplemented with workbooks and audio CDs.
In addition, all participants will receive a graduated exercise prescription of 20-30 minutes of moderate-intensity exercise, five days per week.
They will be instructed to assess the intensity of their exercise using the Borg perceived exertion scale.
Client contact sessions are as follows: Clinic Session (CS)1; Phone Session (PS) 1 (end of week1), CS 2 (end of week 4); PS 2 (end of week 6); CS 3 (end of week 8).
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Patient-reported headache-free days per week
Временное ограничение: 2 weeks prior to treatment through 2 weeks post-treatment
|
Patients are asked to report the number of days per week they do no experience headaches
|
2 weeks prior to treatment through 2 weeks post-treatment
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Headache Disability Index (HDI)
Временное ограничение: baseline, 8 weeks, 10 weeks
|
HDI is a 25-item questionnaire that assesses headache-related functional and emotional disability in chronic headache sufferers.
Participants respond to items using a 3-point scale: "yes," "sometimes," or "no."
|
baseline, 8 weeks, 10 weeks
|
|
Highest weekly headache intensity
Временное ограничение: 2 weeks prior to treatment through 2 weeks post-treatment
|
Patients are asked to report the the intensity of their worst headache during the past week, using a 0 (pain-free) to 10 (extremely intense pain) scale.
|
2 weeks prior to treatment through 2 weeks post-treatment
|
|
Composite Depression/Anxiety Screening Scale (PHQ-4)
Временное ограничение: 2 weeks prior to treatment through 2 weeks follow-up
|
This is a 4-item measure assessing symptoms of anxiety and depression in the past two weeks.
Participants respond on a 4 point scale: 0=Not at all; 1=Several days; 2=More than half of the days; 3=Nearly every day.
When this measure is administered during the course of treatment (weekly) participants will be asked to respond based on their experiences in the past week.
|
2 weeks prior to treatment through 2 weeks follow-up
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Следователи
- Главный следователь: Donald Penzien, Ph.D., University of Mississippi Medical Center
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования
1 декабря 2011 г.
Первичное завершение (Действительный)
1 июня 2012 г.
Завершение исследования (Действительный)
1 августа 2012 г.
Даты регистрации исследования
Первый отправленный
30 января 2012 г.
Впервые представлено, что соответствует критериям контроля качества
30 января 2012 г.
Первый опубликованный (Оценивать)
2 февраля 2012 г.
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
16 января 2013 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
14 января 2013 г.
Последняя проверка
1 января 2013 г.
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 2011-0044
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .